Published in J Biol Chem on June 10, 1979
Role of the vesicular stomatitis virus matrix protein in maintaining the viral nucleocapsid in the condensed form found in native virions. J Virol (1981) 2.23
Binding to cells of virosomes containing herpes simplex virus type 1 glycoproteins and evidence for fusion. J Virol (1984) 2.21
Localization of membrane-associated proteins in vesicular stomatitis virus by use of hydrophobic membrane probes and cross-linking reagents. J Virol (1980) 1.89
Reconstituted G protein-lipid vesicles from vesicular stomatitis virus and their inhibition of VSV infection. J Cell Biol (1980) 1.71
Insertion of influenza M protein into the viral lipid bilayer and localization of site of insertion. J Virol (1981) 1.65
Monoclonal antibodies to the glycoprotein of vesicular stomatitis virus: comparative neutralizing activity. J Virol (1982) 1.54
Interaction of influenza M protein with viral lipid and phosphatidylcholine vesicles. J Virol (1980) 1.34
In vitro cell-free conversion of noninfectious Moloney retrovirus particles to an infectious form by the addition of the vesicular stomatitis virus surrogate envelope G protein. J Virol (1998) 1.26
Role of repetitive antigen patterns for induction of antibodies against antibodies. J Exp Med (1997) 1.18
Functional reconstitution of influenza virus envelopes. EMBO J (1987) 1.13
Interactions of Semliki Forest virus spike glycoprotein rosettes and vesicles with cultured cells. J Cell Biol (1983) 1.06
The glycoprotein isolated from vesicular stomatitis virus is mitogenic for mouse B lymphocytes. J Exp Med (1981) 0.97
Reconstitution of the fusogenic activity of vesicular stomatitis virus. EMBO J (1986) 0.95
Reconstitution of functional membrane-bound acetylcholine receptor from isolated Torpedo californica receptor protein and electroplax lipids. Proc Natl Acad Sci U S A (1980) 0.94
Characterization of T-helper epitopes of the glycoprotein of vesicular stomatitis virus. J Virol (1994) 0.93
Enhanced gene transfer with fusogenic liposomes containing vesicular stomatitis virus G glycoprotein. J Virol (1998) 0.90
Solubilization and reconstitution of vesicular stomatitis virus envelope using octylglucoside. Biophys J (1997) 0.81
Local expression and exocytosis of viral glycoproteins in multinucleated muscle cells. J Cell Biol (1992) 0.80
Disulfide-bonded discontinuous epitopes on the glycoprotein of vesicular stomatitis virus (New Jersey serotype). J Virol (1992) 0.80
Perturbations of phospholipid head groups by membrane proteins in biological membranes and recombinants. Biophys J (1984) 0.80
Cell-mediated cytotoxicity against targets bearing Sendai virus glycoproteins in the absence of viral infection. J Virol (1984) 0.80
Comparative sedimentation coefficients of RNA extracted from plaque-forming and defective particles of vesicular stomatitis virus. J Mol Biol (1966) 6.61
Defective T particles of vesicular stomatitis virus. I. Preparation, morphology, and some biologic properties. Virology (1966) 6.37
Dissociation and reconstitution of the transcriptase and template activities of vesicular stomatitis B and T virions. J Virol (1972) 5.93
Classification of rhabdovirus proteins: a proposal. J Virol (1972) 5.54
Proteins of vesicular stomatitis virus: kinetics and cellular sites of synthesis. J Virol (1970) 4.85
Structural proteins of vesicular stomatitis viruses. J Virol (1969) 4.70
Protein composition of the structural components of vesicular stomatitis virus. J Virol (1969) 4.54
The glycoprotein of vesicular stomatitis virus is the antigen that gives rise to and reacts with neutralizing antibody. J Virol (1972) 4.04
Role of the membrane (M) protein in endogenous inhibition of in vitro transcription by vesicular stomatitis virus. J Virol (1979) 3.54
Defective T particles of vesicular stomatitis virus. II. Biologic role in homologous interference. Virology (1966) 3.49
L protein requirement for in vitro RNA synthesis by vesicular stomatitis virus. J Virol (1973) 3.26
Lipid composition of purified vesicular stomatitis viruses. J Virol (1971) 3.25
Comparison of PCR, isoenzyme analysis, and antigen detection for diagnosis of Entamoeba histolytica infection. J Clin Microbiol (1998) 3.04
Spatial relationships of the proteins of vesicular stomatitis virus: induction of reversible oligomers by cleavable protein cross-linkers and oxidation. J Virol (1977) 2.77
Rat and human colonic mucins bind to and inhibit adherence lectin of Entamoeba histolytica. J Clin Invest (1987) 2.74
Diagnosis of pathogenic Entamoeba histolytica infection using a stool ELISA based on monoclonal antibodies to the galactose-specific adhesin. J Infect Dis (1993) 2.57
Rabbit macrophage interferons. I. Conditions for biosynthesis by virus-infected and uninfected cells. J Exp Med (1967) 2.46
Carbohydrate composition of vesicular stomatitis virus. J Virol (1971) 2.40
Inhibition of cellular RNA synthesis by nonreplicating vesicular stomatitis virus. Proc Natl Acad Sci U S A (1965) 2.37
Cytoplasmic compartmentalization of the protein and ribonucleic acid species of vesicular stomatitis virus. J Virol (1972) 2.37
Rapid diagnosis of Entamoeba infection by using Entamoeba and Entamoeba histolytica stool antigen detection kits. J Clin Microbiol (1995) 2.31
Membrane vesiculation function and exocytosis of wild-type and mutant matrix proteins of vesicular stomatitis virus. J Virol (1995) 2.23
Protein kinase and phosphoproteins of vesicular stomatitis virus. J Virol (1974) 2.11
Temperature-sensitive mutants of vesicular stomatitis virus: synthesis of virus-specific proteins. J Virol (1971) 2.05
Sequence of a cysteine-rich galactose-specific lectin of Entamoeba histolytica. Proc Natl Acad Sci U S A (1991) 2.03
Viral liposomes released from insect cells infected with recombinant baculovirus expressing the matrix protein of vesicular stomatitis virus. J Virol (1993) 2.02
Functional and antigenic domains of the matrix (M1) protein of influenza A virus. J Virol (1987) 1.98
Entamoeba histolytica and Entamoeba dispar infection in children in Bangladesh. J Infect Dis (1997) 1.95
Localization of membrane-associated proteins in vesicular stomatitis virus by use of hydrophobic membrane probes and cross-linking reagents. J Virol (1980) 1.89
Association of vesicular stomatitis virus glycoprotein with virion membrane: characterization of the lipophilic tail fragment. J Virol (1975) 1.88
Ribonucleic acid species of intracellular nucleocapsids and released virions of vesicular stomatitis virus. J Virol (1972) 1.86
Association of serum antibodies to adherence lectin with invasive amebiasis and asymptomatic infection with pathogenic Entamoeba histolytica. J Infect Dis (1990) 1.84
Mapping regions of the matrix protein of vesicular stomatitis virus which bind to ribonucleocapsids, liposomes, and monoclonal antibodies. J Virol (1986) 1.78
Diagnosis of amebic liver abscess and intestinal infection with the TechLab Entamoeba histolytica II antigen detection and antibody tests. J Clin Microbiol (2000) 1.77
Restitution of infectivity to spikeless vesicular stomatitis virus by solubilized viral components. J Virol (1975) 1.77
Entamoeba histolytica: genetic diversity of clinical isolates from Bangladesh as demonstrated by polymorphisms in the serine-rich gene. Exp Parasitol (2001) 1.77
Leptin signaling in intestinal epithelium mediates resistance to enteric infection by Entamoeba histolytica. Mucosal Immunol (2010) 1.76
Cat scratch disease, bacillary angiomatosis, and other infections due to Rochalimaea. N Engl J Med (1994) 1.76
Transcription-inhibition and RNA-binding domains of influenza A virus matrix protein mapped with anti-idiotypic antibodies and synthetic peptides. J Virol (1989) 1.73
Role of matrix protein in assembling the membrane of vesicular stomatitis virus: reconstitution of matrix protein with negatively charged phospholipid vesicles. Biochemistry (1981) 1.71
Inhibition of RNA and interferon synthesis in Krebs-2 cells infected with vesicular stomatitis virus. Virology (1966) 1.67
Regulation of viral transcription by the matrix protein of vesicular stomatitis virus probed by monoclonal antibodies and temperature-sensitive mutants. J Virol (1985) 1.66
Sialoglycoprotein of vesicular stomatitis virus: role of the neuraminic acid in infection. J Virol (1974) 1.63
Action of interferon: kinetics and differential effects on viral functions. J Virol (1970) 1.63
Caspase 3-dependent killing of host cells by the parasite Entamoeba histolytica. Cell Microbiol (2000) 1.62
The plus-strand leader RNA of VSV inhibits DNA-dependent transcription of adenovirus and SV40 genes in a soluble whole-cell extract. Cell (1982) 1.61
Glycoprotein biosynthesis. Incorporation of glycosyl groups into endogenous acceptors in a Golgi apparatus-rich fraction of liver. J Biol Chem (1971) 1.60
Amebic liver abscess. Infect Dis Clin North Am (2000) 1.59
Location of the transcription defect in group I temperature-sensitive mutants of vesicular stomatitis virus. J Virol (1974) 1.58
Mosquito cells infected with vesicular stomatitis virus yield unsialylated virions of low infectivity. J Virol (1975) 1.57
Differential inhibition of host protein synthesis in L cells infected with RNA - temperature-sensitive mutants of vesicular stomatitis virus. J Virol (1976) 1.55
Enveloped viruses as model membrane systems: microviscosity of vesicular stomatitis virus and host cell membranes. Biochemistry (1976) 1.54
Monoclonal antibodies to the glycoprotein of vesicular stomatitis virus: comparative neutralizing activity. J Virol (1982) 1.54
Inhibition of RNA synthesis in mouse myeloma cells infected with vesicular stomatitis virus. J Virol (1978) 1.51
Nucleus-targeting domain of the matrix protein (M1) of influenza virus. J Virol (1995) 1.46
Neutralization of tetanus toxin by distinct monoclonal antibodies binding to multiple epitopes on the toxin molecule. Infect Immun (1984) 1.45
Reversible inhibition of interferon synthesis by puromycin: evidence for an interferon-specific messenger RNA. Proc Natl Acad Sci U S A (1965) 1.44
RNA- temperature-sensitive mutants of vesicular stomatitis virus: L-protein thermosensitivity accounts for transcriptase restriction of group I mutants. J Virol (1976) 1.44
Use of UV irradiation to identify the genetic information of vesicular stomatitis virus responsible for shutting off cellular RNA synthesis. J Virol (1979) 1.44
Transcription inhibition and other properties of matrix proteins expressed by M genes cloned from measles viruses and diseased human brain tissue. J Virol (1994) 1.42
Adherence and cytotoxicity of Entamoeba histolytica or how lectins let parasites stick around. Infect Immun (1994) 1.42
Membrane-binding domains and cytopathogenesis of the matrix protein of vesicular stomatitis virus. J Virol (1994) 1.39
Regulation of adherence and virulence by the Entamoeba histolytica lectin cytoplasmic domain, which contains a beta2 integrin motif. Mol Biol Cell (1998) 1.38
Structural proteins of two salmonid rhabdoviruses. J Virol (1975) 1.36
Prevalence and immune response to Entamoeba histolytica infection in preschool children in Bangladesh. Am J Trop Med Hyg (1999) 1.34
Expression of the M gene of vesicular stomatitis virus cloned in various vaccinia virus vectors. J Virol (1988) 1.33
Classification of the New Jersey serotype of vesicular stomatitis virus into two subtypes. J Virol (1978) 1.32
Enzymatic transfer of 14C-glucosamine from UDP-N-acetyl-14C-glucosamine to endogenous acceptors in a Golgi apparatus-rich fraction from liver. Biochem Biophys Res Commun (1969) 1.32
Inhibition of the complement membrane attack complex by the galactose-specific adhesion of Entamoeba histolytica. J Clin Invest (1992) 1.32
Monoclonal antibodies to the M protein of vesicular stomatitis virus (Indiana serotype) and to a cDNA M gene expression product. J Virol (1985) 1.28
Inhibition of viral transcriptase by immunoglobulin directed against the nucleocapsid NS protein of vesicular stomatitis virus. J Virol (1975) 1.27
Entamoeba histolytica: target cells killed by trophozoites undergo DNA fragmentation which is not blocked by Bcl-2. Exp Parasitol (1994) 1.27
Influence of the peripheral matrix protein of vesicular stomatitis virus on the membrane dynamics of mixed phospholipid vesicles: fluorescence studies. Biochemistry (1983) 1.23
Inhibition of transcription by immunoglobulins directed against the ribonucleoprotein of homotypic and heterotypic vesicular stomatitis viruses. J Virol (1978) 1.22
Infection and immunity mediated by the carbohydrate recognition domain of the Entamoeba histolytica Gal/GalNAc lectin. J Infect Dis (1999) 1.22
Inhibition by aurintricarboxylic acid and polyethylene sulfonate of RNA transcription of vesicular stomatitis virus. J Virol (1975) 1.21
Microviscosity of togavirus membranes studied by fluorescence depolarization: influence of envelope proteins and the host cell. J Virol (1976) 1.21
Transcription of vesicular stomatitis virus is required to shut off cellular RNA synthesis. J Virol (1979) 1.20
Cellular adsorption function of the sialoglycoprotein of vesicular stomatitis virus and its neuraminic acid. J Virol (1975) 1.19
Binding and internalization of rat colonic mucins by the galactose/N-acetyl-D-galactosamine adherence lectin of Entamoeba histolytica. J Infect Dis (1988) 1.19
A tetracycline-inducible gene expression system in Entamoeba histolytica. Mol Biochem Parasitol (1997) 1.19
Relationship of free intracellular calcium to the cytolytic activity of Entamoeba histolytica. Infect Immun (1988) 1.18
Role of the galactose lectin of Entamoeba histolytica in adherence-dependent killing of mammalian cells. Infect Immun (1991) 1.17
Intermediate subunit of the Gal/GalNAc lectin of Entamoeba histolytica is a member of a gene family containing multiple CXXC sequence motifs. Infect Immun (2001) 1.16
Rabbit macrophage interferons. II. Some physicochemical properties and estimations of molecular weights. J Exp Med (1967) 1.16
Use of antiviral-antiferritin hybrid antibody for localization of viral antigen in plasma membrane. J Virol (1971) 1.15
Production of mouse monoclonal antibodies which inhibit in vitro adherence of Entamoeba histolytica trophozoites. Infect Immun (1986) 1.15
High affinity binding of the Entamoeba histolytica lectin to polyvalent N-acetylgalactosaminides. J Biol Chem (1995) 1.15
Characterization of cell surface carbohydrate receptors for Entamoeba histolytica adherence lectin. Infect Immun (1989) 1.14
Antigenicity, function, and conformation of synthetic oligopeptides corresponding to amino-terminal sequences of wild-type and mutant matrix proteins of vesicular stomatitis virus. J Virol (1988) 1.14
Comparative inhibition of cellular transcription by vesicular stomatitis virus serotypes New Jersey and Indiana: role of each viral leader RNA. J Virol (1983) 1.13
Monoclonal antibodies to the glycoprotein of vesicular stomatitis virus (New Jersey serotype): a method for preliminary mapping of epitopes. Virology (1987) 1.12
Viral membranes: model systems for studying biological membranes. CRC Crit Rev Biochem (1979) 1.10
Short report: detection of Entamoeba histolytica and E. dispar directly in stool. Am J Trop Med Hyg (1994) 1.10
Lipid organization of the membrane of vesicular stomatitis virus. J Biol Chem (1978) 1.10
Nucleotide sequence and secondary structure of VSV leader RNA and homologous DNA involved in inhibition of DNA-dependent transcription. Cell (1984) 1.10
Reversal by certain polyanions of an endogenous inhibitor of the vesicular stomatitis virus-associated transcriptase. J Biol Chem (1978) 1.09
Effect of phospholipase C and cholesterol oxidase on membrane integrity, microviscosity, and infectivity of vesicular stomatitis virus. Biochemistry (1977) 1.08
Analysis of the gene family encoding the Entamoeba histolytica galactose-specific adhesin 170-kDa subunit. Mol Biochem Parasitol (1993) 1.07